CS
CLBT icon

Credit Suisse’s Cellebrite CLBT Stock Holding History

Credit Suisse’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$771K Buy
69,583
+5,012
+8% +$51.2K ﹤0.01% 2420
2023
Q4 		$559K Buy
64,571
+10,929
+20% +$84.9K ﹤0.01% 2678
2023
Q3 		$410K Buy
53,642
+19,536
+57% +$147K ﹤0.01% 2787
2023
Q2 		$246K Buy
34,106
+4,158
+14% +$24.2K ﹤0.01% 3061
2023
Q1 		$182K Sell
29,948
-11,581
-28% -$62.8K ﹤0.01% 3133
2022
Q4 		$181K Sell
41,529
-333
-0.8% -$1.49K ﹤0.01% 3214
2022
Q3 		$164K Buy
41,862
+18,961
+83% +$95.1K ﹤0.01% 3311
2022
Q2 		$117K Buy
22,901
+2
+0% +$10 ﹤0.01% 3505
2022
Q1 		$147K Buy
22,899
+125
+0.5% +$829 ﹤0.01% 3438
2021
Q4 		$183K Buy
+22,774
New +$215K ﹤0.01% 4294

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CC
Crosslink Capital Menlo Park, California $1.02B AUM 9.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return

Credit Suisse's CLBT Position: Q1 2024 in Review

Credit Suisse increased its Cellebrite (CLBT) stake by 7.8% in Q1 2024, buying an estimated $51.2K and bringing the position to 69,583 shares worth $771K. The position accounts for ﹤0.01% of the portfolio, ranked #2420.

Credit Suisse first reported a position in CLBT in Q4 2021 and has held it in 10 quarters since. 141 funds tracked by Wall St. Rank hold CLBT as of Q1 2024.

  • Credit Suisse held 69,583 shares of Cellebrite worth $771K as of Q1 2024.
  • Credit Suisse bought 5,012 Cellebrite shares in Q1 2024, an estimated $51.2K.
  • Cellebrite made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2420 holding.
  • Credit Suisse first reported a position in Cellebrite in Q4 2021 and has held it in 10 quarters since.
  • 141 funds tracked by Wall St. Rank held Cellebrite as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.